Siemens Healthcare Diagnostics has published product data including GTINs for its complete U.S. product portfolio to the GHX Health ConneXion™ data pool, which is certified by GS1′s Global Data Synchronization Network (GDSN) to synchronize medical-surgical product data. The GS1 system of standards is the most widely used supply chain standards system in the world. Use of standards has proven highly effective in other industries, such as retail and consumer packaged goods.

Read the full story here

ForteBio®, Inc. announced the launch of its Dip and Read™ Protein G biosensor for rapid detection and quantification of numerous types of mammalian immunoglobulin (IgG), an antibody molecule, from solution. Because it runs on the company’s label-free Octet instrumentation platform, the new biosensor enables such measurements with unprecedented speed, ease of use and cost-efficiency. The company also announced that it has completed International Standards Organization (ISO) certification of its biosensor manufacturing facility.

Read the full story here

A new portable system may improve survival following cardiac arrest compared with standard care procedures, particularly when CPR and cooling are initiated early. Results from a recent study showed that the RhinoChill™ Intra-Nasal Cooling System enabled brain temperature to reach target several hours earlier than patients cooled in the emergency room. It is widely recognized that the sooner brain temperature can be reduced, the better the chances of minimizing long-term damage.

Read the full story here

Spectrum Surgical Instruments Corp. introduces Spectra-Lube®, an easy-to-use, 32-ounce spray-on lubricant designed to protect and lubricate surgical instruments. Spectra-Lube® eliminates the need for costly and messy instrument “baths” by allowing the user to put lubrication where it’s needed. Spectra-Lube® is fully-autoclavable and safe to use on your surgical instruments. Its neutral pH and rust inhibitor prolongs the life of your surgical instruments and reduces any damage and replacement costs from rust or corrosion.

Read the full story here

NeuroVasx, Inc. has announced that the first procedure in Spain utilizing its cPAX Aneurysm Treatment System was performed in Madrid. cPAX received CE Mark earlier this year. The cPAX System is a minimally invasive device for the embolization of cerebral aneurysms, abnormal bulges or sacs in the wall of an artery in the brain. If ruptured, aneurysms can result in massive intracranial bleeding and often lead to death.

For the full story, click here

Medtronic Inc announced the approval of its Attain Ability left-heart lead (Model 4196) by the U.S. Food and Drug Administration (FDA) for use with cardiac resynchronization therapy (CRT) devices for heart failure patients. Attain Ability has the thinnest lead body of any left-heart lead currently available, providing physicians with a tool to deliver therapy directly to hard-to-reach areas of the heart.

SiDMAP, LLC, has expanded its SiDTox™ services to enable rapid and specific detection of drug-induced organ toxicity. Using its proprietary metabolomics technology platform, SiDMAP is able to monitor changes in vital metabolite fluxes in response to drug treatment to quickly determine organ toxicity before structural or morphological damage occurs. On the basis of a research performed by SiDMAP along with the Center for Metabolomics at the FDA National Center for Toxicological Research, SiDTox™ will now include an affordable and non-invasive test that will allow researchers to detect drug-induced toxicity before organ damage.